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Acute pancreatitis (AP) is the most serious emergent disease in the gastroenterology 
field. The most common cause of AP is naturally gallstones. The most cases have mild 
disease and the illness limits itself in a short time period. In 15–20% of cases, the severe 
form of acute biliary pancreatitis (ABP) develops. Some patients have concomitant 
cholangitis. In these patients, releiving biliary obstruction with endoscopic retrograde 
cholangiography (ERCP) and endoscopic sphincterotomy (ES) is essential. However, 
correct timing of ERCP is a debate. While some authors and guidelines suggested that 
ERCP can be performed in first 24 hours, the others suggested its use during the first 
72 hours. In the first 24 hours, ERCP is diffucult to apply due to ampullary edema and 
general ill situation of the patient. Rather than ERCP, agressive fluid replacement 
and supportive therapy are very much important in the first 72 hours of admission. 
Moreover, there is no consensus on timing of ERCP in patients with severe pancreatitis 
without cholangitis. But all international guidelines suggested that ERCP should be 
perfomed in all patients with mild or severe pancreatitis together with concomitant 
cholangitis during the first 72 hours. After resolution of ABP, cholecystectomy should 
be performed to prevent recurrent pancreatitis during the same hospitalization period 
(index cholecystectomy). If the patient is not suitable for cholecystectomy, ERCP and 
ES should be done to prevent further attacks of acute pancreatitis.
Keywords: acute biliary pancreatitis, urgent ERCP, early ERCP, endoscopic 
sphincterotomy, biliary duct stone
1. Introduction
Acute pancreatitis (AP) is the most serious emergent disease in the gastroenter-
ology field. The most common cause of AP is naturally gallstones. The most cases 
have mild disease and the illness limits itself in a short time period. In 15–20% of 
cases, the severe form of AP develops. The triage of patients with AP in accordance 
with the severity of illness is the single most important factor affecting monitorisa-
tion and treatment protocol of these patients. Acute biliary pancreatitis (ABP) 
develops due to gall stones and or sludge mostly coming from gall bladder, impacted 
in ampulla Vateri (AV) leading to increased pancreatic ductal pressure, pancreatic 
edema, inflammation and possibly necrosis. A lot of human and animal studies 
displayed that biliary obstrucition lasting more than 48 hours creates pancreatic 
necrosis. Therefore, before the endoscopic retrograde cholangiography (ERCP) 
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area, surgery was used to induce biliary decompression and impede progression into 
pancreatic necrosis, however, new quests started after facing high rate of morbidi-
ties and mortalities associated with surgery.
Introduction of ERCP and endoscopic sphincterotomy into the daily practice, 
endoscopic relieving of biliary obstruction has come into reality. Nevertheless, 
occurence of complications even mortalitiy in association with ERCP initiated new 
debate about its indications and timing in patients with ABP. Although for the last 
30 years, there has been many ongoing studies about to whom and when ERCP will 
be perforrmed in ABP, a certain conclusion has not been encountered yet. There has 
been 2 main strategies on debate [1].
1. Early routine ERCP strategy: If acute gallstone pancreatitis is triggered by 
duct obstruction caused by a stone, it would be reasonable to suggest that 
early ERCP with removal of any residual stones might reduce the severity of 
pancreatitis. The strategy of early ERCP is strongly supported by results from 
experimental studies and human studies, which show that the duration of 
biliary obstruction is a major factor in determining the severity of pancreatitis 
and that decompression of the biliary system can prevent progression of the 
disease. In addition, patients with severe pancreatitis tended to have stones 
impacted in the ampulla, and early (within 48 hours) surgical decompression 
of the obstruction has been shown to decrease mortalite rates These observa-
tions lend support to the theory of using early ERCP to remove obstructing 
stones in acute gallstone pancreatitis.
2. Early conservative management with or without delayed or selective use of 
ERCP strategy: Proponents of early conservative management with selective use 
of ERCP argue that early routine ERCP may lead to many unnecessary ERCPs 
in the majority of patients as the offending gallstone has often passed before 
the diagnosis of pancreatitis is made. Also, it remains unclear whether early 
ERCP improves the prognosis of acute gallstone pancreatitis. The severity of the 
pancreatitis may be determined at its inception and may not be dependent on 
the duration of duct obstruction. Furthermore, performing ERCP in the setting 
of acute pancreatitis can be technically difficult because of swollen ampulla and 
duodenal wall. Thus, it may be prudent to identify patients with persistent duct 
obstruction who would benefit from ERCP after a period of conservative medi-
cal management in order to avoid unnecessary negative ERCPs.
Due to 2 different approaches, how an imminent ERCP will affect the existing 
clinical situation in patients with ABP holds its uncertainity. There has been also 
no agreement on the preference of an urgent ERCP (U-ERCP) within 24 hours of 
patients’admission or an emergent ERCP (E-ERCP) within 48–72 hours [2]. These 
terms; U-ERCP and E-ERCP have been used in recent reports and the first paper 
published by Neoptolemos and et al. defined U-ERCP and E-ERCP differently than 
the other papers; the first one within 72 hours and the later within 35 days after 
admission [3]. Later on, ERCP within first 72 hours was labeled as U-ERCP [4] 
and after the year of 2000, U-ERCP has been defined as ERCP within 24 hours and 
E-ERCP as ERCP within 24–72 hours [2]. In severe ABP, there are some risks such 
as patient’s bad general situation, technical difficulties due to pancreatic edema and 
potential interruption of aggressive fluid resuscitation during and after the ERCP 
procedure. Therefore, valid only for patients having persisting indication for biliary 
decompression, seveal authors and our clinical experience favor E-ERCP together 
with immense supportive treament of these patients rather than U-ERCP in the 
absence of life threatining cholangitis.
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In severe cases with AP, there can be pain, fever, cholestasis, mental confusion 
and hypotension due to ongoing pancreatic inflammation and necrosis and under 
this circumstances, an imminent ERCP can make the situation even worser [5]. 
Although, if we scrutinize the real life data, we will see that there is some kind of 
pressure on ERCP physicians to perform ERCP at night and or at weekends by the 
physicians seeing these patients with ABP in the emergency room [6]. However, 
in severe ABP, it would be impossible to guarentee the co-existence of cholangitis 
only by looking at some clinical and biochemical parameters, the use of harmless 
non-invasive methods such as magnetic resonance cholangiography (MRCP) and 
or endoscopic ultrasonography (EUS) seems to be more reasonable. Hence, endos-
copist who will perform ERCP should estimate the clinical situation of patient with 
ABP correctly and know very well to whom and when ERCP should be done. Thirty 
four years after the first report by Neoptolemus [3] suggesting wider application 
of ERCP with ES during AP, Schepers NJ [4] reported a multicentric article (APEC 
study) which underlined the fact that U-ERCP with ES does not reduce AP associ-
ated complications and mortality compated with conservative approaches. These 
authors supported a conservative strategy in severe ABP with ERCP indicated only 
in patients with cholangitis or persistant cholestasis.
In this chapter, we will mention about the role of ERCP during ABP in accor-
dance with the clinical studies and meta-analysis published on this subject and we 
will add our self clinical experience and practice in this area. The order of titles will 
be as such,
• The pathogenesis and natural history of ABP
• The estimation of cholangitis and cholestasis
• The treatment steps in the first 72 hours in reference to International 
Guideliness
• To whom and when ERCP should be done during ABP?
2. The pathogenesis and natural history of ABP
In the setting of ABP, biliary stones or sludge material impacted in ampulla 
vateri induce transient obstruction in the biliary tree and pancreatic ductus, 
followed by reflux of bile into the pancreatic channel. Consequently, undrain-
ing pancreatic channel develops increased ductal pressure leading to backflow of 
activated pancreatic enzymes into the parenchyma. This starts a cascade of tissue 
injury with a spectrum of events starting with mild parencymal inflammation 
ending with loss of pancreatic parenchyma due to severe necrosis [7]. For sure, 
cholestasis and or cholangitis due to biliary obstruction in addititon to pancreatic 
inflammation can add into the clinical scenario. There are several evidences indi-
cating the duration of obstruction correlates with te severity of pathology in the 
pancreas. These evidences reveal that persisting obstruction after 48 hours leads to 
different degrees of necrosis and if the ductal decompression is obtained before that 
time period, disease associated morbidity and mortality decreases significiantly 
[8–16]. Runzi et al. [8] used an animal model of AP by balloon obstructed biliopan-
creatic ductal system and they relieved the obstruction at 1th, 3rd and 5th days. The 
authors documented that the severity of parenchymal inflammation, fat necrosis, 
hemorrhage, acinar cell vacuolisaiton and necrosis were most prominent in animals 
with obstructed ductal sysytem at 5 th days of the experiment. On contrary, animals 
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having decompressed ductal sysytem at 1th and 3 rd day of experiment, pancreatic 
injury was able to be avoided. Another report by Acosta et al. [11] investigating the 
same subject on a clinical study put forth that severe pancreatitis develops signifi-
cantly more in patients with the obstruction lasting more than 48 hours compared 
to those having less than 48 hours of obstruction. These authors suggested to wait 
for 48 hours to implement an ERCP as the impacted stone may fall down spontane-
ously and if the signs of obstruction persists after 48 hours, then we should think 
about ERCP. On the grounds that at least half of the cases, the impacted stone in 
Ampulla Vateri will fall down spontaneously within 24–48 hours after ampullary 
and duodenal edema diminishes, we know that the pancreatitis in these patients will 
limit itself and recover within a few days. Acosta et al. [12] investigated the effects 
of early ductal decompression in a report and they compared 30 patients who 
underwent ERCP within first 48 hours with 31 patients who got only conservative 
treatment. Within the first group, 16 had passed the stone into the duodenum dur-
ing 48 hours and only 14 patients underwent ERCP in whom 11 were shown to have 
impacted stones. In the second group of patients, 22 patients had got rid of obstuc-
tion spontaneously and 9 patients who had persistent signs of obstruction under-
went ERCP and only 3 of them had impacted stone. As a result, %78 of patients 
passed stones spontaneously into the duodenum and E-ERCP was performed on 
the others within 48 hours without an uneventful clinical course and mortality. 
Another report by Cavdar et al. [13] indicated that 74% of patients with ABP passed 
stones into the duodenum within 72 hours of admission.
Based on all this data and our clinical experience about the natural progression 
of ABP, we suggest conservative approach during the first 24 to 48 hours to limitate 
the severity of pancreatitis by agressive fluid recessuation correction hypovolemia 
and organ hypoperfusion. This approach also allows us to evaluate the patients with 
regard to the presence of cholestasis and cholangitis and to find out which patients 
need ductal decompression.
APACHE II, Ranson, Glasgow veya Atlanta criteria are used to evaluate the 
severity of AP. Cholangitis and or cholestasis are assessed according to the pres-
ence or absence of severe pain, mental confusion, hipotansiyon, jaundice, elevated 
serum bilirubin ve liver enzymes and absence of bile in the aspirated gastric juice. 
Acosta and et al. [14] clearly demonstrated that absence of bile in the aspirated gas-
tric juice hyperbilirubinemia and severe pain are the parameters most sensitive and 
spesific for the ongoing obstruction of AV. The authors concluded to apply ERCP 
to this subgroup of patients. However, these findings may also occur in patients 
with severe pancreatitis and do not indicate the existence of cholangitis. Thus, 
ERCP performed based only on these findings may worsen pancreatitis, even end 
up with death. Therefore, we need better methods to show the stone in the biliary 
tree. Before the area of MRCP and endoscopic ultrasonography (EUS), we would do 
diagnostic ERCP and endoscopic sphincterotomy in every patient with a diagnosis 
of ABP even if we did not detect gall stones in the bile duct. This policy has changed 
to ‘never do diagnostic ERCP in ABP’ and do first MRCP or if possible more sensi-
tive EUS to decide if ERCP will be done or not.
3. The estimation of cholangitis and cholestasis
On clinical practice, the presence of cholangitis and or cholestasis in a patient 
with ABP is estimated by clinical and biochemical parameters together with 
abdominal ultrasonography (USG) [15–19]. Severe abdominal pain, fever, mental 
confusion, hypotension and jaundice can be seen in severe acute pancreatitis even in 
the absence of cholangitis. In 20% of patients, the liver enzymes can be persistently 
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normal. The sensitivity of abdominal USG is very low around 27–50% in the diag-
nosis of cholestasis and cholangitis. The bile duct diameter can persist several days 
after spontaneously passing stones. Thus, we need more sensitive methods to detect 
cholangitis and or cholestasis. Nearly 20 years ago, ERCP has been widely used for 
a diagnostic purpose. However, there have been important developments with the 
administration of MRCP and EUS into the gastroenterology practice [20–29]. EUS 
is better than MRCP to detect gall stones smaller than 5 mm and after detecting the 
stone by EUS and as an adavantage of this procedure, ERCP can be used to extract 
the stone from the bile duct at the same session after EUS procedure [21–27]. Moon 
and his collagues [28] reported the accuracy rates of USG, computed tomography, 
MRCP, ERCP and intraductal USG to detect bile duct stones are 20%, 40%, %80%, 
90%, 95%, respectively. The authors underlined IDUS and ERCP as the most 
sensitive methods to detect a CBD stone and suggested to use MRCP to choose the 
suitable patient for ERCP. They also notified that the rate of agreement between 
ERCP and MRCP is 90.6% and the large common bile duct has been mentioned as a 
factor for MRCP to overlook the bile duct stones.
MRCP has a low diagnostic value compared to EUS in a patient with dilated 
CBD having small sized stones. Scheiman and his colleagues [29] investigated and 
compared the cost and clinical efficacy of EUS and MRCP done 24 hours before 
the ERCP procedure. The authors identified EUS as the best cost-effective modal-
ity to prevent unnecessary ERCP. Thus, this will protect patients from potential 
complications of ERCP. Furthermore, 20% of bile duct stones smaller than 8 mm 
and detected by MRCP were found to pass spontaneously into the duodenum until 
the time comes for an ERCP procedure. Thus, EUS will reliably help us to give final 
decision to do ERCP or not. Another advantage of EUS is its applicability on bed 
side for patients warded in intensive care units. Additionally, in patients with nor-
mal gall bladder evaluation on percutaneous USG, EUS can detect sludge in the gall 
bladder in the setting of ABP. We can also use a quick EUS examination performed 
within 72 hours of hospitalization to decide if patients can be discharged early from 
the hospital. This strategy can decrease the health expanses as well. Thus, it seems 
very rational to increase cost effectivity of caring for ABP patients by provoking the 
motivation of ERCP physicians to get learn how to do EUS and vice versa [25–27].
4.  First 72 hours treatment steps according to the International 
Guideliness
Severe cases with ABP should be hospitalized in spesific centers having MRCP, 
ERCP and preferably EUS facilities under the control of a team of physicians 
consisted of gastroenterologist, pancreatobiliary surgeon and invasive radiologist 
[30–35]. First, the severity of AP in accordance with the international scoring 
models must be determined and the patient’s co-morbidities should be recorded. 
Thereafter, these patients should be vigorously hydrated to prevent the col-
lapse of pancreatic circulation. Indeed, we will especially emphasize aggressive 
fluid replacement therapy in these patients in the first 3 days of admission with 
patients with AP. This issue is also very important for the prophylaxis of post-
ERCP pancreatitis [36].
A meticiluos fluid replacement within this very 24 hours limits pancreatitis by 
correcting the hypovolemia and organ hypoperfusion, hinders local and systemic 
complications of AP by decreasing Systemic Inflammatory Response Syndrome 
(SIRS) and associated multiorgan failure and lowers inhospital mortality. This 
helps to improve the general status of the patient and decreases the risks of further 
invasive procedures like ERCP in these circumstance. During the first 24 hours, 
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iv crystalloid and or colloid solutions can be given [30–35, 37, 38]. Although a 
retrospective study depicted no difference between ringer lactate (RL) and normal 
saline (SF) infusion with regard to the severity and complications of pancreatitis 
[39], there are vast data from the experimental and clinical studies supporting the 
benefits of RL; such as RL infusion hampers hyperchloremic acidosis and other 
metabolic complications of AP and by improvinng intraparenchymal pH status, 
RL infusion inhibits zymogen activation and worsening of AP [40, 41]. For these 
reasons, RL has been suggested by many international guidelines as first choice to 
be used as fluid therapy in these patients with AP [30–36]. In the absence of heart 
and kidney failure, RL infusion at 5–10 ml/kg/hour dose within the first 24 hours is 
recommended to these patients as targeted fluid therapy. By this way, we aim to get 
normal hemodynamic parameters, urine output 0.5–1 ml/kg/hour and hematocrit 
value as between 35–44%. However, we need to be scrupulous to avoid hypervol-
emia in elderly patients during fluid recesutation. Therefore, it is important to limit 
the dose to 5 to 10 ml/kg/hour as more than 10 ml/kg/hr. infusion rate has been 
associated with mehcanical ventilation, abdominal compartment syndorme and 
increased mortality [42].
5. ERCP when and to whom in ABP?
Before 1978 when Classen [43] first did ERCP and endoscopic sphincterotomy 
in acute pancreatitis, ERCP was considered as contraindicated in AP. Thereafter, 
this dogma has changed by Safrany and his collegeus [44] who did ERCP in 15 cases 
with ABP in 1980. They detected impacted stone at AV in 8 patients and in 7 of 
them, they showed choledochal stone and removed the stones in all the patients. 
None of the patients developed any complications and discharged withn a short 
period after ERCP procedure. After 1980, case series have been reported in this 
area and first randomized controlled study about this subject was published by 
Neoptolemos and his collegues in 1986 [3]. In 1993, Fan and et al. [45] published 
a report in which they investigated the effects of early ERCP on progression of 
AP. The authors showed that early ERCP was useful only in patients with biliary 
sepsis compared to conservative group if there is an existing biliary pathology both 
in mild and severe cases of AP. However, early ERCP did not introduce declined 
morbidity and mortality when all other etiologies of AP had been included in the 
study cohort.
Nonetheless, many complications associated with ERCP have been reported 
in the following years and when and to whom ERCP questions became subject to 
many researches. ERCP and endoscopic sphincteratomy can make the situation 
worse in a patient with AP since therapautic ERPC had been reported to have 10% 
morbidity and 0.1% mortality rates [46, 47]. Additioanlly in patients with AP, there 
is potential risk of technical failure in ERCP procedure due to edema in the AV and 
duodenum itself.
For this reason, both the timing of ERCP and detrmining the correct patient who 
needs this procedure carry the utmost importance. In 2013, International Pancreas 
Union and American Pancreas Union published together ‘the management guideli-
ness of AP’ and the suggestions about biliary system problems were written as 
follows [31]:
1. “ERCP is not indicated in predicted mild biliary pancreatitis without chol-
angitis. (GRADE 1A, strong agreement). ERCP is probably not indicated in 
predicted severe biliary pancreatitis without cholangitis (GRADE 1B, strong 
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agreement). ERCP is probably indicated in biliary pancreatitis with com-
mon bile duct obstruction (GRADE 1C,strong agreement) ERCP is indicated 
in patients with biliary pancreatitis and cholangitis (GRADE 1B, strong 
agreement)
2. Urgent ERCP (<24 hrs) is required in patients with acute cholangitis. Currently, 
there is no evidence regarding the optimal timing of ERCP in patients with bili-
ary pancreatitis without cholangitis.(GRADE 2C, strong agreement)
3. MRCP and EUS may prevent a proportion of ERCPs that would otherwise 
be performed for suspected common bile duct stones in patients with bili-
ary pancreatitis who do not have cholangitis, without influencing the clinical 
course. EUS is superior to MRCP in excluding the presence of small (<5 mm) 
gallstones. MRCP is less invasive, less operator-dependent and probably more 
widely available than EUS. Therefore, in clinical practice there is no clear supe-
riority for either MRCP or EUS.(GRADE 2C, strong agreement)”
Therefore, we will discuss the subject of bliary tree management in patients 
with AP as subtitiles; 1-Mild pancreatitis in the absence of cholangitis and 
persistent cholestasis. 2- Severe pancreatitis in the absence of cholangitis and 
persistent cholestasis 3- Acute pancreatitis together with the presence of cholan-
gitis and persistent cholestasis. We will also discuss; 4- U-ERCP versus E-ERCP 
and 5-the role of elective ERCP 3 days after patient’s admission to prevent  
recurrence of AP.
5.1 ERCP in patients without cholangitis or persistent cholestasis
The first randomized controlled trial in this field is published by Neoptolemus 
et al. in 1986 [3]. No relationship was found related to pancreatitis complications 
and mortality between the conservative treatment group and the ERCP group 
in mild acute biliary pancreatitis patients in this study and in the meta-analysis 
which contains 4 randomized controlled studies of Sharma et al. [48]. The 
patients were stratified by the severity of pancreatitis in the study of Burstow  
et al. [49] but the patients with or without cholangitis were not analyzed sepa-
rately and eventually, a strong tendency to decrease pancreatitis complications 
has been suggested in patients with mild acute biliary pancreatitis, although this 
is not statistically significant (OR 0.67; 95% CI, 0.43, 1.03; P = 0.06). Another 
meta-analysis of 5 randomized controlled studies including 702 patients, which 
compared the conservative treatment and E-ERCP in acute biliary pancreatitis 
patients by Morietti et al. [50] showed no effect on pancreatitis complications 
(1.8% (95% CI -5.6% to 9.3%); p = 0.6). Since there is no mortality in patients 
with mild pancreatitis, a comparison could not be made in this regard. Petrov et 
al. [51] did not demonstrate any statistically significant difference between the 
E-ERCP group and the conservative treatment group in terms of reducing compli-
cations of pancreatitis in neither mild nor severe acute pancreatitis in their meta-
analysis of 5 randomized controlled studies including 717 patients. A systematic 
review by Geenen et al. that published in Pancreatology in 2013 [52] examined the 
guidelines and meta-analysis in this field till then, reported that U or E-ERCP±ES 
had no place in mild acute biliary pancreatitis. As we do in our clinical practice, 
Elective ERCP (EL-ERCP) might be performed before the cholecystectomy only 
in case, the stuck stones in AV have escaped back into the choledoc and if this is 
proved by MRCP or EUS.
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As a result, there is consensus that U or E-ERCP±ES is not indicated in mild 
acute biliary pancreatitis without cholangitis [31, 33–35].
5.2  Emergency ERCP in severe acute biliary patients without cholangitis or 
persistent cholestasis
ERCP in acute biliary pancreatitis is still a controversial issue, and there no 
consensus about it. As mentioned before, clinical and animal studies showed 
that if the biliary obstruction is not terminated within 48 hours, the pathology 
progresses to necrosis and then organ failure occurs. Therefore, the first studies 
demonstrated that U or E-ERCP decreased the mortality and morbidity in severe 
acute pancreatitis patients compared to the control group [53]. In 1997, Fölsch et al. 
[54] reported that especially deaths due to respiratory failure were more common 
in the E-ERCP group than the control group in their randomized controlled trial 
about the role of E-ERCP in acute biliary pancreatitis. The APEC study [4] that 
includes 232 patients from 26 centers published in July 2020 compared U-ERCP 
and conservative treatment, and this study changed the paradigm. Besides, acute 
biliary pancreatitis patients with cholangitis excluded from the APEC study and no 
significant difference demonstrated between two groups in regard of local or sys-
temic complications of pancreatitis. Whereas, the cholangitis and recurrent attacks 
of pancreatitis were more common in the U-ERCP group than the conservative 
treatment group. This is because the criteria for persistent cholestasis or cholangitis 
were fever, serum bilirubin levels greater than 2.3 mg / dl, commom bile duct width 
greater than 8 millimeters in patients younger than 75 years and 1 centimeter in 
patients older than 75 years, and the presence of stones in common bile duct in this 
study. Another cause of these findings were that it was unclear whether MRCP or 
EUS, which are the most sensitive methods in detecting stones in choledoc, were 
performed or not.
Some conflicting results were obtained in the meta-analysis of randomized 
controlled trials about the role of emergency ERCP in acute biliary pancreatitis, 
according to the including and excluding criteria of the involved randomized 
controlled trials and whether subgroup analysis is done or not. Petrov et al. [55] 
published a meta-analysis in 2008 including 7 randomized controlled trials with 
450 patients about the effects of E-ERCP on acute biliary pancreatitis without 
cholangitis, and they indicated that emergency ERCP has no effect on local compli-
cations of pancreatitis in neither mild nor severe pancreatitis. Van Santvoort et al. 
[56] compared E-ERCP with conservative treatment in patients with and without 
cholangitis in their randomized controlled trial and demonstrated that in patients 
without cholestasis, ERCP (29/75 patients: 39%) was not associated with reduced 
complications (45% vs. 41%, P = 0.814, multivariate adjusted OR: 1.36; 95% CI: 
0.49–3.76; P = 0.554) or mortality (14% vs. 17%, P = 0.754, multivariate adjusted 
OR: 0.78; 95% CI: 0.19–3.12, P = 0.734).
A meta-analysis by Tse et al. [1] which contains 5 randomized controlled stud-
ies, indicated that unweighted pooled mortality rates for participants were 9.6% in 
the early routine ERCP strategy and 4.9% in the early conservative management 
strategy in patients without cholangitis. Three years after this meta-analysis, 
Burstow et al. [49] analyzed 11 RCTs consisting of 1314 patients (conservative 
management = 662, ERCP = 652). There was a near significant decrease in mor-
tality for the ERCP group compared with conservatively managed patients with 
severe pancreatitis [odds ratio (OR) 0.45; 95% confidence interval (CI), 0.19, 1.09; 
P = 0.08]. In patients with mild pancreatitis, mortality results were comparable for 
both groups (OR 0.66; 95% CI, 0.02, 28.75; P = 0.83). Overall complications were 
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significantly reduced in the ERCP group in severe pancreatitis patients (OR 0.32; 
95% CI, 0.17,0.61; P = 0.00). The authors’ comments about this meta-analysis are as 
follows: this meta-analysis demonstrates a significant decrease in complications in 
patients with severe ABP managed with early ERCP/ES compared with conserva-
tive management. As far as the mortality is concerned, no significant decrease was 
observed in mortality even in severe ABP patients treated with early ERCP/ES.
The meta-analysis and systematic review about the comparison of E-ERCP 
and conservative treatment in acute biliary pancreatitis by Coutinho et al. [57] 
reported that; the pain and fever resolved in a shorter time, the hospitalization 
time was shorter with reduced complications and hospital costs were lower in the 
E-ERCP group than the conservative treatment group. Uy et al. [58] performed a 
meta-analysis including 2 randomized controlled trials that compares the E-ERCP 
(n = 177) and the conservative treatment (n = 163) in acute biliary pancreatitis. This 
meta-analysis revealed low mortality rates for both mild and severe pancreatitis in 
the ERCP group (RR = 1.92, 95% CI: 0.86–4.32) whereas the morbidity rates were 
similar in both groups (RR = 0.95, 95% CI: 0.74–1.22). Moretti et al. [50] demon-
strated that ERCP had no effect on complications in mild pancreatitis however, 
ERCP reduced the complications in severe pancreatitis but it did not have any 
effect on mortality rates in their meta-analysis including 5 prospective randomized 
trials with 702 patients. Geenen et al. [52] preformed a review including 12 inter-
national guidelines and 8 meta-analysis. Although 3 meta-analysis and 1 guideline 
recommended against ERCP in acute biliary pancreatitis, 7 out of 11 guidelines 
recommended routine E-ERCP in severe acute biliary pancreatitis regardless of the 
presence of cholangitis, and they agreed on the lack of consensus about routine 
E-ERCP in severe acute biliary pancreatitis. However, the 4 main international 
guidelines that we evaluated (2 out of them belonged the same group but published 
at different times) recommended against the emergency ERCP in acute biliary pan-
creatitis without cholangitis because it did not significantly reduce mortality and 
morbidity compared to the conservative treatment group [31, 33–35]. Contrary to 
these guidelines, another guideline of the United Kingdom publishe in 2005 [32] has 
controversial suggestions about E-ERCP in severe acute biliary pancreatitis without 
cholangitis as; “Urgent therapeutic endoscopic retrograde cholangiopancreatography 
(ERCP) should be performed in patients with acute pancreatitis of suspected or proven 
gall stone etiology who satisfy the criteria for predicted or actual severe pancreatitis, or 
when there is cholangitis, jaundice, or a dilated common bile duct. “.
Because of the lack of statically significant data about the reduction in local and 
systemic complications or mortality rates of pancreatitis by emergency ERCP in 
severe acute biliary pancreatitis from many RCTs and meta-analyzes until to date, 
international guidelines referring to these results indicated that U- or E-ERCP have 
no benefit in every patient with severe acute biliary pancreatitis unless cholangitis 
is present. The ESGE guideline published in 2018 [33] explains why ERCP should 
not be performed in a patient with severe pancreatitis without cholangitis: “A 
possible explanation why urgent ERCP with sphincterotomy within 24 h did not show an 
advantage over conservative treatment could be that the opportunity to positively influ-
ence the disease course had already passed at the time of the ERCP despite the fact that it 
was performed early. Animal models have shown that trypsinogen activation within the 
pancreas occurs within10 min after chemically inducing pancreatitis. It is well known 
that most bile duct stones in patients with gallstone pancreatitis cause only temporary 
obstruction and pass spontaneously into the duodenum. This temporary obstruction 
already initiates pancreatitis and data from animal models show that this includes 
intrapancreatic trypsin activation, rupturing of vacuoles releasing active trypsin, and 
pancreatic autodigestion. In the current trial, urgent ERCP was done after a median 29 
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h after onset of symptoms and common bile duct stones were found in 43% of patients. 
Even this narrow time window might already be too long to prevent pancreatitis from 
deteriorating by performing an urgent ERCP with sphincterotomy”.
5.3  Emergency ERCP in acute biliary patients with cholangitis or persistent 
cholestasis
Certainly, biliopancreatic obstruction should be resolved immediately in patients 
with cholangitis or persistent cholestasis. The most effective method of this is 
undoubtedly the removal of stone or sludge that caused the obstruction by perform-
ing ERCP and ES [59]. The first study in this area was performed by Neoptolemos 
et al. and it demonstrated that E-ERCP and ES was the most useful method in acute 
biliary pancreatitis with cholangitis and cholangitis without pancreatitis [60]. Van 
Santvoort et al. [56] performed a study about the efficiency of ERCP in acute pan-
creatitis patient with or without cholestasis and findings as follows: In patients with 
cholestasis, ERCP (52/78 patients: 67%), as compared with conservative treatment, 
was associated with fewer complications (25% vs. 54%, P = 0.020, multivariate 
adjusted odds ratio [OR]: 0.35, 95% confidence interval [CI]: 0.13–0.99, P = 0.049). 
This included fewer patients with >30% pancreatic necrosis (8% vs. 31%, 
P = 0.010). Mortality was nonsignificantly lower after ERCP (6% vs. 15%, P = 0.213, 
multivariate adjusted OR: 0.44, 95% CI: 0.08–2.28, P = 0.330).
Tse et al. [1] performed a meta-analysis which included 5 randomized controlled 
trials with 644 participants with cholangitis and reported mortality rates, compris-
ing a total of 200 participants in the early routine ERCP strategy and 215 in the early 
conservative management strategy. Unweighted pooled mortality rates for partici-
pants were 1.0% for the early routine ERCP strategy and 6.9% in the early conserva-
tive management strategy. In the trials that included participants with cholangitis, 
the early routine ERCP strategy significantly reduced mortality compared to the 
early conservative management strategy (RR 0.20, 95% CI 0.06 to 0.68; P = 0.010).
5.4  U-ERCP or E-ERCP in acute biliary pancreatitis with cholangitis or 
persistent cholestasis?
There is no consensus on timing of ERCP in the literature. In most publications, 
the ERCP preformed within 72 hours after the symptom onset is called emergency 
ERCP, but the emergency ERCP timing could be defined as within 48 hours in some 
other publications. Additionally, the ERCP which is performed within 72 hours 
named as U-ERCP in some publications. The only trial that compares the timing 
of ERCP (within 24 hours versus within 24–72 hours) in acute biliary pancreatitis 
is performed by Lee et al. [2]. Patients with acute biliary pancreatitis but without 
cholangitis was excluded retrospectively in this study, and they compared U-ERCP 
and E-ERCP in acute biliary pancreatitis. No significant difference was found in the 
total length of hospitalization or procedural-related complications, in patients with 
biliary pancreatitis and a bile duct obstruction without cholangitis, according to the 
timing of ERCP (< 24 h vs. 24–72 h). Although the definition is not U-ERCP, in one 
of Fan et al.’s studies [45] the ERCP which is performed within 24 hours is defined 
as E-ERCP and there was no significant difference between the ERCP group and 
the conservative treatment group in terms of local and systemic complications of 
pancreatitis whereas hospitalization time was a little shorter in the E-ERCP group. 
With these results, it was demonstrated that performing U-ERCP within 24 hours 
did not change the pancreatitis course, supporting the study of Lee et al. [2]. When 
considering the course of acute biliary pancreatitis, naming the ERCP performed 
within 24 hours as “URGENT” and the ERCP within 24–72 hours as “EARLY” by 
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Lee et al. is the most appropriate definition [2]. When the literature and interna-
tional guidelines are reviewed, ERCP is recommended to the acute biliary pancre-
atitis within 24 hours if the cholangitis is present and within 72 hours if the biliary 
obstruction is present, instead of this definition.
Although the naming does not resemble, recommendation of ESGE in this 
respect is as follows: “ESGE recommends urgent (≤ 24 hours) ERCP and biliary 
drainage in patients with acute biliary pancreatitis combined with cholangitis. Strong 
recommendation, high quality of evidence. ERCP should be performed within 72 hours 
in patients with ongoing biliary obstruction. Weak recommendation, moderate quality 
evidence. It should not be performed in patients with acute biliary pancreatitis and 
neither cholangitis or ongoing bile duct obstruction. Weak recommendation, moderate 
quality evidence” [33]. According to our clinical experience; although there is a 
need for randomized prospective trials on this subject, the absence of difference 
between performing the ERCP within 24 hours or within 24–72 hours leads to 
escape gastroenterologist or endoscopists from the regression of performing ERCP 
within 24 hours in a rush and off-duty, which is believed to be the reason of high 
rates of complications such as aggrevation of pancreatitis, possible bilioportal reflux 
in patients with cholangitis during ERCP, bacteriemia or systemic complications 
(i.e., organ failure) by depriving the patient’s opportunity to receive extensive fluid 
therapy and broad-spectrum antibiotics within the most important 24 hours for the 
complications.
5.5 Elective ERCP to prevent pancreatitis recurrence
Early laparoscopic or open cholecystectomy as soon as AP recovers completely 
is the only proven treatment modality to prevent recurrence of ABP. Index chole-
cystectomy is defined as cholecystectomy applied during the same hospitalization 
period of ABP and interval cholcystectonmy is cholecystectomy performed 6 weeks 
after patient’s recovery from AP [61].
Sinha and colleagues [61] reported that index cholecystectomy in a case suitable 
for surgery has similar results with elective cholecystectomy in a patient without AP 
and they also reported significant difficulty to do dissection during interval chole-
cystectomy. In 2019, Fu-ping Zhung and colleagues [62] published a meta-analysis 
of 19 studies enrolling 2639 who underwent index or interval cholecystectomy. 
They noted that there was no differences with ragard to intraoperative and postop-
erative complications, duration of operation and the rates of open cholecystectomy. 
However, index cholecystectomy cases had lesser hospitalization period, lower 
biliary complications due to surgery and lesser rates of ERCP.
In cases with severe pancreatitis, most of the time it is impracticable to perform 
index cholcystectomy. Therefore, interval cholcystectomy is obligatory in these 
cases. Infortunately, these patients reamit with AP attacks and ot biliary complica-
tions during this 6 weeks period. Thus some authors offer ERCP and endoscopic 
sphincteratomy to prevent AP recurrences and or biliary complications to ocur 
during this time period [63, 64].
In a retrospective study comparing index cholecystectomy and post ERCP/ES 
plus interval cholecystectomy, both group of patients did not reveal mortality. Only 
2 patients (%5) developed AP recurrences and acute cholecystitis and hospitalized. 
The authors suggested that ERCP/ES is highly successful to prevent recurrences in 
patients with severe ABP who can not undergo index cholecystectomy. ES and inter-
val cholecystectomy in severe ABP is considered a reasonable alternative to an index 
cholecystectomy in patients with severe ABP [64].
Another report by Dedemadi and his colleagues [65] published in 2016 
noted that ERCP and ES in cases with AP who can not undergo cholecystectomy 
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developed biliary events 0%–28.6%, recurrent pancreatitis 0%–8.2%, mortality 
3%–4.7%. Other cases under conservative treatment had biliary events 9.4%–14.3%, 
recurrent pancreatitis 12%–23%, mortality 3.9%. Statistical evaluation showed that 
ERCP and ES group had significanly less biliary complications and less recurrent 
pancreatitis with no difference in mortality compared to conservative treatment 
group. The conservative group consisted of patients who were elderly persons with 
multiple comorbidites and complications of AP. These conditions may be respon-
sible for similar mortality rates in both groups. Nevertheless, because of high rates 
of biliary events and pancreatitis in the ERPC/ES group, this approach should be 
reserved only for patients not suitaable for cholecystectomy.
The advice of IAP/APA about timing od cholecystectomy in a case with ABP is as 
follows [31]:
5.5.1 “Timing of cholecystectomy (or endoscopic sphincterotomy)
1. Cholecystectomy during index admission for mild biliary pancreatitis appears safe 
and is recommended. Interval cholecystectomy after mild biliary pancreatitis isasso-
ciated with a substantial risk of readmission for recurrent biliary events, especially 
recurrent biliary pancreatitis.(GRADE 1C, strong agreement).
2. Cholecystectomy should be delayed in patients with peripancreatic collections until 
the collections either resolve or if they persist beyond 6 weeks, at which time chole-
cystectomy can be performed safely.(GRADE 2C, strong agreement).
3. In patients with biliary pancreatitis who have undergone sphincterotomy and are 
fit for surgery, cholecystectomy is advised, because ERCP and sphincterotomy pre-
vent recurrence of biliary pancreatitis but not gallstone related gallbladder disease, 
i.e. biliary colic and cholecystitis.(GRADE 2B, strong agreement)”.
Moreover, If we consider surgery for pancreatic cystic collections, pseudocysyt 
and or walled off necrosis, it should be performed at the same time with cholecys-
tectomy [65].
6. Conclusion
We want to finish with the conclsuive statement made by ESGE [35]; “In 
conclusion, urgent ERCP with sphincterotomy did not reduce the composite endpoint 
of major complications or mortality in patients with predicted severe gallstone pan-
creatitis, compared with conservative treatment. These findings support a conserva-
tive strategy with an ERCP indicated only in patients with cholangitis or persistent 
cholestasis. With this conservative strategy, about two-thirds of patients did not need 
to undergo ERCP”. In the presence of cholangitis, ERCP as E-ERCP should be done 
only after hemodynamic stabilisation and relieved organ hipoperfusion with 
aggressive fluid replacement and antibiotic treatment within the first 24 hours, 
Elective ERCP to prevent ABP attacks is suggested only for patients unsuitable for 
an choecystectomy procedure.
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